Budget Airline Reinventing Itself Pulls Ahead in 2026
In 2026, the budget airline reinventing itself is pulling ahead as it monetizes upgrades and smarter distribution, wh...
Why Use Cash App For Savings
Explore the benefits of using Cash App for savings. This platform offers unique features that can help you grow your funds effectively.
24,982 articles
Meta Spending $145 Billion on AI Push Reshapes Markets
Meta Platforms unveils a multi-year AI infrastructure push totaling up to $145 billion, reshaping supplier valuations...
How to Build $3,000 Month Dividend Income Before 50
As markets wobble in mid-2026, investors are increasingly pursuing steady dividend cash flow to supplement earnings. ...
Procter & Gamble vs PepsiCo: Better Stock for Passive Income Now
PepsiCo drives growth with international momentum while Procter & Gamble shines in beauty; both set the stage for a d...
Vistra’s 2026 Guidance Reinforces Its Growth Path Ahead
Vistra reports record 2025 EBITDA and unveils a 2026 target that points to sustained growth. The company cites long-t...
This $2.9 Billion Fund Sustains 26-Year Payout Streak
A $2.9 billion closed-end fund has paid distributions every year since 2000, marking a 26-year streak. Here’s how the...
After Buffett’s Successor Purge, Berkshire Concentrates
In Q1, Berkshire Hathaway slashed 16 holdings, leaving 26 positions and pushing four top stocks to dominate more than...
Saylor's Strategy Boosts Reserves by $450M Without Selling BTC
Strategy increases its USD cash pile by $450 million via a stock offering, bringing total USD reserves to $3 billion ...
Live Earnings: Complete Zscaler Coverage and Market Reaction
Zscaler posted a strong quarter, beating revenue and EPS estimates while signaling durable ARR growth. Here are the n...
Live: Will Oklo Smash Q1 Earnings Tonight, Market Reacts
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Abbott Labs Pfizer: Which Is the Bigger Value Trap Now
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status